Royalty Pharma PLC (RPRX)
25.80
+0.10
(+0.37%)
USD |
NASDAQ |
Nov 18, 16:00
25.80
0.00 (0.00%)
After-Hours: 17:24
Royalty Pharma Price: 25.80 for Nov. 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 15, 2024 | 25.23 | 25.88 | 25.10 | 25.70 | 3.844M |
Nov 14, 2024 | 25.90 | 25.96 | 25.36 | 25.58 | 3.031M |
Nov 13, 2024 | 26.00 | 26.20 | 25.80 | 25.85 | 2.529M |
Nov 12, 2024 | 26.25 | 26.41 | 25.82 | 26.00 | 3.148M |
Nov 11, 2024 | 26.30 | 26.60 | 26.12 | 26.36 | 2.785M |
Nov 08, 2024 | 26.61 | 26.80 | 26.08 | 26.21 | 5.979M |
Nov 07, 2024 | 27.01 | 27.03 | 26.30 | 26.52 | 2.583M |
Nov 06, 2024 | 28.13 | 28.36 | 26.56 | 26.64 | 4.599M |
Nov 05, 2024 | 27.12 | 27.56 | 26.95 | 27.54 | 1.820M |
Nov 04, 2024 | 27.52 | 27.59 | 27.16 | 27.20 | 1.603M |
Nov 01, 2024 | 27.00 | 27.27 | 26.99 | 27.10 | 1.810M |
Oct 31, 2024 | 27.08 | 27.26 | 26.96 | 27.00 | 1.900M |
Oct 30, 2024 | 27.07 | 27.37 | 26.94 | 27.19 | 2.518M |
Oct 29, 2024 | 27.13 | 27.33 | 27.08 | 27.15 | 1.832M |
Oct 28, 2024 | 27.10 | 27.28 | 27.02 | 27.26 | 1.985M |
Oct 25, 2024 | 27.35 | 27.38 | 26.94 | 26.95 | 1.629M |
Oct 24, 2024 | 27.24 | 27.45 | 27.18 | 27.28 | 1.591M |
Oct 23, 2024 | 27.27 | 27.49 | 27.19 | 27.36 | 1.449M |
Oct 22, 2024 | 27.60 | 27.70 | 27.32 | 27.37 | 2.383M |
Oct 21, 2024 | 27.95 | 28.00 | 27.64 | 27.75 | 1.693M |
Oct 18, 2024 | 28.12 | 28.27 | 27.81 | 27.98 | 1.178M |
Oct 17, 2024 | 28.14 | 28.20 | 27.80 | 28.05 | 1.852M |
Oct 16, 2024 | 27.80 | 28.35 | 27.78 | 28.22 | 2.178M |
Oct 15, 2024 | 27.75 | 28.38 | 27.72 | 27.84 | 1.817M |
Oct 14, 2024 | 27.94 | 28.05 | 27.70 | 27.87 | 1.315M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.58
Minimum
Nov 14 2024
52.82
Maximum
Jan 26 2021
36.92
Average
38.73
Median
Aug 13 2021
Price Benchmarks
Geron Corp | 3.765 |
Amicus Therapeutics Inc | 9.665 |
Ionis Pharmaceuticals Inc | 33.74 |
Arbutus Biopharma Corp | 3.53 |
Syndax Pharmaceuticals Inc | 16.10 |
Price Related Metrics
PE Ratio | 10.12 |
PS Ratio | 6.786 |
Price to Book Value | 1.668 |
Price to Free Cash Flow | 5.494 |
Earnings Yield | 9.89% |
Market Cap | 11.46B |
Operating PE Ratio | 9.961 |
Normalized PE Ratio | 13.16 |